Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05927311

Side Effects of Antibiotics in Bone and Joint Infections

Prospective Study : Side Effects of Antibiotics in Bone and Joint Infections

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Treatment for bone and joint infection (BJI) is not standardized, which allows a wide range of antibiotic therapy to potentially be given, most often in high doses over long periods of time. Patients are regularly confronted with the adverse effects of these antibiotics, which can lead to loss of adherence and treatment failure. The frequency, severity and impact on quality of life of the adverse effects of long-term antibiotics will be studied in a cohort followed for one year.

Detailed description

Treatment for bone and joint infection is not standardized, which allows a wide range of antibiotic therapy to potentially be given, most often in high doses over long periods of time. Patients are regularly confronted with the adverse effects of these antibiotics, which can lead to loss of adherence and treatment failure. Although patients with BJI receive regular follow-up, the impact of adverse events during treatments lasting more than a month is still poorly developed in the literature. The frequency, severity and impact on quality of life of the adverse effects of long-term antibiotics will be studied in a cohort followed for one year. The investigators believe that this study will improve the management of osteoarticular infections through a better understanding of the adverse effects associated with prolonged, high-dose antibiotic therapy, and encourage more multidisciplinary follow-up.

Conditions

Timeline

Start date
2023-08-11
Primary completion
2025-02-01
Completion
2025-08-01
First posted
2023-07-03
Last updated
2024-12-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05927311. Inclusion in this directory is not an endorsement.